Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q4 2016 · 10-K
Revenue$1.47M$1.47M−5.8% vs Q4 2015 Net Income-$4.92M-$4.92MN/M vs Q4 2015 EPS Diluted-$0.24-$0.24N/M vs Q4 2015 Gross Profit$521,000−31.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
derived
Operating Cash Flowderived-$4,161,000N/M Free Cash Flowderived-$4,118,000N/M Margins · derivedGross margin35.5%−13.6 pt vs Q4 2015
Operating margin-244.7%−111.2 pt vs Q4 2015
Net margin-335.5%−158.3 pt vs Q4 2015
ended Dec 31, 2016 · filed Mar 24, 2017 · 83 d after period end